Voichita Bar Ad, MD
Voichita Bar Ad, MD
University of Medicine and Pharmacy, Timisoara, Romania
Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
Most Recent Peer-Reviewed Publications
- A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors
- In-Field Toxicity Analysis of a Phase 1 Clinical Trial of Nivolumab and Ipilimumab With Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
- Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck
- PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy
- Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial
- Radiation Oncology in Israel - 2003
- American Board of Radiology (Radiation Oncology) - 2009
Research & Clinical Interests
I am a board-certified radiation oncologist who specializes in the use of intensity modulated radiation therapy (IMRT) and dose painting in the treatment of technically challenging cancers to maximize therapeutic gain while minimizing side effects from treatment.
I have extensive clinical experience in the treatment of various solid tumors including head and neck, gastrointestinal tract, lung, breast, and brain cancers. By working closely with our talented radiation physics staff, our team can choose among various highly technical approaches to optimize the outcome for each patient as we endeavor to balance highly effective and safe treatments. These techniques include not only IMRT technique, but also volumetric modulated arc therapy (VMAT), stereotactic body radiation therapy (SBRT), stereotactic radiosurgery (SRS), cyberknife. I have a particular interest in the use of IMRT in the treatment of patients with head and neck cancers. I often work closely with my medical oncology colleagues to combine chemotherapy, targeted agents, and radiation therapy in the treatment of these cancers.
I also participate in the institutional and national clinical trials to help bring state-of-the-art cancer care to her patients at Thomas Jefferson University.